STEVEN C. GILMAN - 07 Jun 2021 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Nicole R. Hadas, attorney-in-fact for Steven C. Gilman
Issuer symbol
AKBA
Transactions as of
07 Jun 2021
Net transactions value
-$15,163
Form type
4
Filing time
09 Jun 2021, 16:26:29 UTC
Previous filing
03 Jun 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $15,163 -4,567 -8.7% $3.32 47,997 07 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.